Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP247681.RAFqHhB3w9Wn-XFTfMGCUYCqcHhfkNOedV9XmeTr-x5gc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP247681.RAFqHhB3w9Wn-XFTfMGCUYCqcHhfkNOedV9XmeTr-x5gc130_assertion type Assertion NP247681.RAFqHhB3w9Wn-XFTfMGCUYCqcHhfkNOedV9XmeTr-x5gc130_head.
- NP247681.RAFqHhB3w9Wn-XFTfMGCUYCqcHhfkNOedV9XmeTr-x5gc130_assertion description "[Inhibition of both SRC and BCR-ABL kinase activities by dasatinib affords complete B-ALL remission.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247681.RAFqHhB3w9Wn-XFTfMGCUYCqcHhfkNOedV9XmeTr-x5gc130_provenance.
- NP247681.RAFqHhB3w9Wn-XFTfMGCUYCqcHhfkNOedV9XmeTr-x5gc130_assertion evidence source_evidence_literature NP247681.RAFqHhB3w9Wn-XFTfMGCUYCqcHhfkNOedV9XmeTr-x5gc130_provenance.
- NP247681.RAFqHhB3w9Wn-XFTfMGCUYCqcHhfkNOedV9XmeTr-x5gc130_assertion SIO_000772 17077147 NP247681.RAFqHhB3w9Wn-XFTfMGCUYCqcHhfkNOedV9XmeTr-x5gc130_provenance.
- NP247681.RAFqHhB3w9Wn-XFTfMGCUYCqcHhfkNOedV9XmeTr-x5gc130_assertion wasDerivedFrom befree-20140225 NP247681.RAFqHhB3w9Wn-XFTfMGCUYCqcHhfkNOedV9XmeTr-x5gc130_provenance.
- NP247681.RAFqHhB3w9Wn-XFTfMGCUYCqcHhfkNOedV9XmeTr-x5gc130_assertion wasGeneratedBy ECO_0000203 NP247681.RAFqHhB3w9Wn-XFTfMGCUYCqcHhfkNOedV9XmeTr-x5gc130_provenance.